YRD:NYSEYiren Digital Ltd. Analysis
Data as of 2026-05-12 - not real-time
$1.96
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Yiren Digital Ltd. (YRD) is trading at $1.96, well below its 20‑day ($2.06), 50‑day ($2.38) and 200‑day ($4.38) simple moving averages, signaling a bearish technical backdrop. The stock’s 30‑day volatility is extreme at 63% and beta of 1.45 indicates heightened market sensitivity, while volume trends are decreasing, further underscoring liquidity concerns. Fundamentally, revenue has slumped 34% YoY, profit margins are razor‑thin (0.7%), and free cash flow is deeply negative ($‑2.34 B), despite a solid cash balance and minimal debt.
Recent material news reveals a suspended dividend, a sharp earnings decline, and an investor‑alert investigation, amplifying both financial and legal risk. Nonetheless, the market price is dramatically below book (P/B 0.13) and sales (P/S 0.03) multiples, and the DCF model suggests a fair value near $112, implying a potential valuation disconnect. The company’s inclusion in the S&P Global Sustainability Yearbook adds a modest ESG positive, but the dominant narrative remains one of short‑term distress and high uncertainty.
Recent material news reveals a suspended dividend, a sharp earnings decline, and an investor‑alert investigation, amplifying both financial and legal risk. Nonetheless, the market price is dramatically below book (P/B 0.13) and sales (P/S 0.03) multiples, and the DCF model suggests a fair value near $112, implying a potential valuation disconnect. The company’s inclusion in the S&P Global Sustainability Yearbook adds a modest ESG positive, but the dominant narrative remains one of short‑term distress and high uncertainty.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 3/10
Key Factors
- Price below all major moving averages
- Suspended dividend and negative earnings
- High volatility and decreasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- Uncertain turnaround amid weak revenue growth
- Legal investigation adds downside risk
- Valuation gap suggests possible upside if fundamentals improve
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Deep discount to book and sales multiples
- DCF fair value indicates sizable upside
- Potential recovery in Chinese credit market and ESG recognition
Key Metrics & Analysis
Financial Health
Revenue Growth-34.10%
Profit Margin0.71%
P/E Ratio21.8
ROE0.43%
ROA10.17%
Debt/Equity0.43
P/B Ratio0.1
Op. Cash Flow$686.7M
Free Cash Flow$-2344241408
Industry P/E16.5
Technical Analysis
TrendBearish
RSI42.2
Support$1.87
Resistance$2.34
MA 20$2.06
MA 50$2.38
MA 200$4.38
MACDBullish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
Fair Value$111.97
GradeUndervalued
TypeValue
Dividend Yield27.16%
Risk Assessment
Beta1.45
Volatility62.95%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.